SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001437749-20-001160
Filing Date
2020-01-24
Accepted
2020-01-24 16:35:48
Documents
3
Group Members
BRADLEY J. HAYOSHJEFFREY S. STARMANLAKEVIEW ASSET MANAGEMENT LLCWICKFIELD PROPERTIES, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D equid20200122_sc13d.htm SC 13D 143351
2 EXHIBIT A ex_170208.htm EX-99.A 17096
3 EXHIBIT B ex_170209.htm EX-99.B 17617
  Complete submission text file 0001437749-20-001160.txt   179683
Mailing Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Pharmaceuticals Corp. (Subject) CIK: 0001684144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90186 | Film No.: 20545928
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 HURONVIEW BLVD. ANN ARBOR MI 48103
Business Address 230 HURONVIEW BLVD. ANN ARBOR MI 48103 7343692100
EQUIDEBT LLC (Filed by) CIK: 0001753306 (see all company filings)

IRS No.: 455450489 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SC 13D